3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Specimen Handling
40
Magnetic Resonance Spectroscopy
27
Carboplatin
19
Gemcitabine
18
Biopsy
17
Cyclophosphamide
15
pembrolizumab
14
fludarabine
14
Paclitaxel
14
Cisplatin
14
Oxaliplatin
12
Injections
12
Dexamethasone
12
Radiotherapy
11
Nivolumab
10
Interviews as Topic
10
venetoclax
8
Irinotecan
8
Fluorouracil
8
Capecitabine
8
Bevacizumab
8
cemiplimab
7
X-Rays
7
Radiosurgery
7
Bortezomib
7
toripalimab
6
Rituximab
6
Pemetrexed
6
Drug Therapy
6
Doxorubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
×
30 days
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled